CRISPRa Lipid Nanocomplex‐Mediated Mt3 Targeting Enhances Astrocytic Endocytosis of Amyloid‐β in an Alzheimer's Disease Mouse Model
Advanced Science · 2026-01 · 13 (4)
DOI: 10.1002/advs.202503725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.12.2025. Verfasst von Junhang Park und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Genetics, College of Pharmacy, Chungbuk National University, Cheongju, 28160, Republic of Korea. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Astrocytes, Endocytosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea government (MSIT), Bio & Medical Technology Development Program of the National Research Foundation (NRF), National Research Council of Science & Technology (NST).
Themen: Demenz
Abstract (Originalsprache)
Metallothionein 3 (Mt3) is crucial for cellular homeostasis and neuroprotection, with accumulating evidence linking it to amyloid‐beta (Aβ) clearance by astrocytes. This study developed a CRISPR activator (CRISPRa) system using lipid nanoparticles to selectively upregulate Mt3 in astrocytes, aiming to enhance Aβ endocytosis in an Alzheimer's disease (AD) mouse model. To directly assess the therapeutic potential of Mt3 activation in a specific brain region, stereotaxic injection is utilized to deliver the CRISPRa lipid nanocomplexes. This approach enabled precise in vivo brain delivery and Mt3 activation. The findings reveal that CRISPRa lipid nanocomplex‐mediated Mt3 upregulation significantly boosts Aβ uptake by astrocytes, leading to a marked reduction in Aβ plaque accumulation in AD mouse brains. These results highlight CRISPRa lipid nanocomplex‐mediated Mt3 targeting as a promising strategy to enhance endogenous Aβ clearance, presenting a novel therapeutic avenue for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Genetics, College of Pharmacy, Chungbuk National University, Cheongju, 28160, Republic of Korea.
- Center for Gene & Cell Therapy, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Chungcheongbuk-do, 28116, Republic of Korea.
- College of Veterinary Medicine, Jeonbuk National University, Iksan, 54596, Republic of Korea.
- College of Pharmacy, Chungbuk National University, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju, 28160, Republic of Korea.
ORCID-Profile: Boyoung Kim, Chun-Woong Park, Hanseul Park
Förderung
- Korea government (MSIT)
- Bio & Medical Technology Development Program of the National Research Foundation (NRF)
- National Research Council of Science & Technology (NST)
Zitieren
APA
Park, J., Kim, B., Ha, M., Park, M., Ryu, H., Yu, H., Park, S., Roh, Y. S., Lim, K. H., Hong, J. T., Han, S. B., Park, C. W., Yong, S. B., & Park, H. (2026). CRISPRa Lipid Nanocomplex‐Mediated Mt3 Targeting Enhances Astrocytic Endocytosis of Amyloid‐β in an Alzheimer's Disease Mouse Model. Advanced Science, 13(4). https://doi.org/10.1002/advs.202503725
Vancouver
Park J, Kim B, Ha M, Park M, Ryu H, Yu H, et al. CRISPRa Lipid Nanocomplex‐Mediated Mt3 Targeting Enhances Astrocytic Endocytosis of Amyloid‐β in an Alzheimer's Disease Mouse Model. Advanced Science. 2026;13(4). doi:10.1002/advs.202503725
BibTeX
@article{Park2026,
author = {Park, Junhang and Kim, Boyoung and Ha, Minki and Park, Moonsu and Ryu, Hongji and Yu, Hyerin and Park, Sungsoo and Roh, Yoon-Seok and Lim, Key-Hwan and Hong, Jin Tae and Han, Sang-Bae and Park, Chun-Woong and Yong, Seok-Beom and Park, Hanseul},
title = {CRISPRa Lipid Nanocomplex‐Mediated Mt3 Targeting Enhances Astrocytic Endocytosis of Amyloid‐β in an Alzheimer's Disease Mouse Model},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {4},
doi = {10.1002/advs.202503725}
}
EUVIMED